Growth hormone action in puberty: Effects by gender

Growth Hormone and IGF Research

Volumn 17, Issue 6, 2007, Pages 463-471

  Mauras, Nelly ^a   Bishop, Kim ^a   Welch, Susan ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

Author keywords

Adiponectin; Body composition; Bone mineral density; IGF I; Insulin; Lipids; Lipolysis; Protein metabolism

Indexed keywords

ADIPONECTIN; CARBON 13; GLUCOSE; GLYCEROL; GROWTH FACTOR; GROWTH HORMONE; HORMONE; INSULIN; LEUCINE; LIPID; PROTEIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADOLESCENCE; ADOLESCENT; ARTICLE; BODY COMPOSITION; BONE DENSITY; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONAL THERAPY; HORMONE ACTION; HORMONE DETERMINATION; HORMONE SENSITIVITY; HUMAN; LIPID BLOOD LEVEL; LIPOLYSIS; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PUBERTY; SEX DIFFERENCE; SHORT STATURE; STRENGTH;

ADOLESCENT; BODY COMPOSITION; CARBOHYDRATE METABOLISM; CARBON ISOTOPES; CHILD; DWARFISM, PITUITARY; FEMALE; GROWTH; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPID METABOLISM; MALE; PROTEINS; PUBERTY; SEX CHARACTERISTICS;

EID: 35848968477     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.04.011     Document Type: Article

References (50)

1. Cuttler L., Silvers J.B., Singh J., Marrero U., Finkelstein B., Tannin G., and Neuhauser D. Short stature and growth hormone therapy: a national study of physician recommendation patterns. JAMA 276 (1996) 531-537
2. Giustina A., and Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19 (1998) 717-797
3. Lahuna O., Fernandez L., Karlsson H., Maiter D., Lemaigre F.P., Rousseau G.G., Gustafsson J., and Mode A. Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone. Proc. Natl. Acad. Sci. USA 94 (1997) 12309-12313
4. Sharma M.C., Agrawal A.K., Sharma M.R., and Shapiro B.H. Interactions of gender, growth hormone, and phenobarbital induction on murine Cyp2b expression. Biochem. Pharmacol. 56 (1998) 1251-1258
5. Robertson G.R., Farrell G.C., and Liddle C. Sexually dimorphic expression of rat CYP3A9 and CYP3A18 genes is regulated by growth hormone. Biochem. Biophys. Res. Commun. 242 (1998) 57-60
6. Drake W.M., Coyte D., Camacho-Hubbner C., Jivanji N.M., Kaltsas G., Wood D.F., Trainer P.J., Grossman A.B., Besser G.M., and Monson J.P. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J. Clin. Endocrinol. Metab. 83 (1998) 3913-3919
7. Burman P., Johansson A.G., Siegbahn A., Vessby B., and Karlsson F.A. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J. Clin. Endocrinol. Metab. 82 (1997) 550-555
8. Hayes F.J., Fiad T.M., and McKenna T.J. Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy. Metabolism 48 (1999) 308-313
9. Johannsson G., Bjarnason R., Bramnert M., Carlsson L.M., Degerblad M., Manhem P., Rosen T., Thoren M., and Bengtsson B.A. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J. Clin. Endocrinol. Metab. 81 (1996) 1575-1581
10. Johansson A.G. Gender difference in growth hormone response in adults. J. Endocrinol. Invest. 22 (1999) 58-60
11. Johansson A.G., Engstrom B.E., Ljunghall S., Karlsson F.A., and Burman P. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J. Clin. Endocrinol. Metab. 84 (1998) 2002-2007
12. Bengtsson B.A., Abs R., Bennmarker H., Monson J.P., Feldt-Rasmussen U., Hernberg-Stahl E., Westberg B., Wilton P., and Wuster C. The effects of treatment and the individual responsiveness to growth hormone(GH) replacement therapy in 665 GH-deficient adults, KIMS Study Group and the KIMS International Board. J. Clin. Endocrinol. Metab. 84 (1999) 3929-3935
13. Kuromaru R., Kohno H., Ueyama N., Hassan H.M., Honda S., and Hara T. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J. Clin. Endocrinol. Metab. 83 (1998) 3890-3896
14. Cohen P., Bright G.M., Rogol A.D., Kappelgaard A.M., and Rosenfeld R.G. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J. Clin. Endocrinol. Metab. 87 (2002) 90-98
15. Tanner J.M., and Whitehouse R.H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch. Dis. Child. 51 (1976) 170-179
16. McArdle W.D., Katch F.I., and Katch V.L. Exercise Physiology: Energy, Nutrition and Human Performance. fourth ed. (1996), Lippincott Williams & Wilkins, Baltimore pp. 180-213
17. Copeland K.C., Kenney F.A., and Nair K.S. Heated dorsal hand vein sampling for metabolic studies: a reappraisal. Am. J. Physiol. 263 (1992) E1010-E1014
18. 2H stable isotopic tracers. Anal. Biochem. 205 (1992) 172-178
19. Schwenk W.F., Berg P.J., Beaufrere B., Miles J.M., and Haymond M.W. Use of t-butyldimethyl-silyation in gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron impact ionization. Anal. Biochem. 141 (1984) 101-109
20. 2. Biomed. Mass. Spectrom. 6 (1979) 350-355
21. Schwenk W.F., Beaufrere B., and Haymond M.W. Use of reciprocal pool specific activities to model leucine metabolism in humans. Am. J. Physiol. 249 (1985) E646-E650
22. Wolfe R.R., and Chinkes D.L. Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis. second ed. (2005), Wiley-Liss, Hoboken, NJ
23. Ferranini E. The theoretical bases of indirect calorimetry: a review. Metabolism 37 (1988) 287-301
24. Celniker A.C., Chen A.B., Wert Jr. R.M., and Sherman B.M. Variability in the quantitation of circulating growth hormone using commercial immunoassays. J. Clin. Endocrinol. Metab. 68 (1989) 469-476
25. Rosenfeld R.G., Albertsson-Wikland K., Cassorla F., Frasier S.D., Hasegawa Y., Hintz R.L., Lafranchi S., Lippe B., Loriaux L., Melmed S., Preece M.A., Ranke M.B., Reiter E.O., Rogol A.D., Underwood L.E., and Werther G.A. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J. Clin. Endocrinol. Metab. 80 (1985) 1532-1540
26. Mauras N., Walton P., Nicar M., Welch S., and Rogol A.D. Growth hormone stimulation testing in both short and normal statured children: use of an immunofunctional assay. Pediatr. Res. 48 (2000) 614-618
27. Gandrud L.M., and Wilson D.M. Is growth hormone stimulation testing in children still appropriate?. Growth Horm. IGF-1 Res. 14 (2004) 185-194
28. Mauras N., Haymond M.W., Darmaun D., Vieira N.E., Abrams S.A., and Yergey A.L. Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone. J. Clin. Invest. 93 (1994) 1014-1019
29. Horber F.F., and Haymond M.W. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J. Clin. Invest. 86 (1990) 265-272
30. Mauras N., O'Brien K.O., Welch S., Rini A., Helgeson K., Vieira N.E., and Yergey A.L. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J. Clin. Endocrinol. Metab. 85 (2000) 1686-1694
31. Mauras N. Estrogens do not affect whole-body protein metabolism in the prepubertal female. J. Clin. Endocrinol. Metab. 80 (1995) 2842-2845
32. Mauras N., Rini A., Welch S., Sager B., and Murphy S.P. Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys. Metabolism 52 (2003) 964-969
33. Blackman M.R., Sorkin J.D., Munzer T., Bellatoni M.F., Busby-Whitehead J., Stevens T.E., Jayme J., O'Connor K.G., Christmas C., Tobin J.D., Stewart K.J., Cottrell E., Clair C.St., Pabst K.M., and Harman S.M. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288 (2002) 2282-2292
34. DiGirolamo M., Eden S., Enberg G., Isaksson O., Lonnroth P., Hall K., and Smith U. Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes. FEBS Lett. 205 (1986) 15-19
35. Vance M.L., and Mauras N. Growth hormone therapy in adults and children. N. Eng. J. Med. 341 (1998) 1206-1216
36. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency: summary statement of the GH research society workshop on adult GH deficiency, J. Clin. Endocrinol. Metab. 83 (1998) 379-381.
37. Beauville M., Harant I., Crampes F., Riviere D., and Tauber J.P. Effect of long term rhGH administration in GH-deficient adults on fat cell epinephrine response. Am. J. Physiol. 263 (1992) E467-E472
38. Yang S., Bjorntorp P., Liu S., and Eden S. Growth hormone treatment of hypophysectomized rats increases catecholamine-induced lipolysis and the number of beta-adrenergic receptors in adipocytes: no differences in the effects of growth hormone on different fat depots. Obes. Res. 4 (1996) 471-478
39. Marcus C., Bolme P., Micha-Johansson G., Margery V., and Bronnegard M. Growth hormone increases the lipolytic sensitivity for catecholamines in adipocytes from healthy adults. Life Sci. 54 (1994) 1335-1341
40. Healy M.L., Gibney J., Pentecost C., Croos P., Russell-Jones D.L., Sonksen P.H., and Umpleby A.M. Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes. J. Clin. Endocrinol. Metab. 91 (2006) 320-327
41. Gibney J., Healy M.L., Stolinski M., Bowes S.B., Pentecost C., Breen L., McMillan C., Russell-Jones D.L., Sonksen P.H., and Umpleby A.M. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults. J. Clin. Endocrinol. Metab. 88 (2003) 1792-1797
42. Vahl N., Juul A., Jørgensen J.O., Ørskov H., Skakkebæk N.E., and Christiansen J.S. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. J. Clin. Endocrinol. Metab. 85 (2000) 1874-1881
43. Attanasio A.F., Howell S., Bates P.C., Frewer P., Chipman J., Blum W.F., Shalet S.M., and composition B. IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. J. Clin. Endocrinol. Metab. 87 (2002) 3368-3372
44. Johansson G., Albertsson-Wikland K., and Bengtsson B.A. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J. Clin. Endocrinol. Metab. 84 (1999) 4516-4524
45. Mauras N., Pescovitz O.H., Allada V., Messig M., Wajnrajch M.P., and Lippe B. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. J. Clin. Endocrinol. Metab. 90 (2005) 3946-3955
46. Colao A., Somma C.D., Salerno M., Spinelli L., Orio F., and Lombardi G. The cardiovascular risk of GH-deficient adolescents. J. Clin. Endocrinol. Metab. 87 (2002) 3650-3655
47. Underwood L.E., Attie K.M., and Baptista J. Genentech Collaborative Study Group, Growth hormone (GH) dose-response in young adults with childhood onset GH deficiency: a two-year, multicenter, multiple-dose, placebo controlled study. J. Clin. Endocrinol. Metab. 88 (2003) 5273-5280
48. Soares D.V., Conceicao F.L., Brasil R.R., Spina L.D., Lobo P.M., Silva E.M., Buescu A., and Vaisman M. Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference. Growth Horm. IGF-1 Res. 14 (2004) 436-441
49. Martha Jr. P.M., Gorman K.M., Blizzard R.M., Rogol A.D., and Veldhuis A.D. Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. J. Clin. Endocrinol. Metab. 74 (1992) 336-344
50. Rose S.R., Shulman D.I., Larsson P., Wakley L.R., Wills S., and Bakker B. Gender does not influence prepubertal growth velocity during standard growth hormone therapy-analysis of United States KIGS data. J. Pediatr. Endocrinol. Metab. 18 (2005) 1045-1051